NCT00116662已完成2 期
A Single-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Resiquimod Gel Applied 3 Times Per Week for up to 12 Weeks for the Treatment of Common Warts in Pediatric Subjects
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 84
- 试验地点
- 19
- 主要终点
- Clearance of treated common wart(s)
研究概览
简要总结
The primary purpose of this study is to evaluate the effectiveness in pediatric subjects of three different strengths of resiquimod gel applied to common wart(s) three times a week for up to twelve weeks.
A second purpose is to evaluate the safety of the drug.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- Single
入排标准
- 年龄范围
- 3 Years 至 11 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of common wart(s)
- •Ages between 3 to 11
排除标准
- •Other types of wart(s), ie. plantar
- •Currently participating in another clinical study
- •Chronic viral hepatitis B or C
结局指标
主要结局
Clearance of treated common wart(s)
次要结局
- Partial clearance of treated common wart(s)
- Wart recurrence
研究者
研究点 (19)
Loading locations...
相似试验
已完成
2 期
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric SubjectsWartsNCT00116675Graceway Pharmaceuticals, LLC84
已完成
2 期
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in AdultsWartsNCT00115141Graceway Pharmaceuticals, LLC88
已完成
2 期
Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in AdultsWartsNCT00114920Graceway Pharmaceuticals, LLC88
终止
不适用
Trial Evaluating Ambulatory Treatment of Travelers' DiarrheaAcute Watery DiarrheaDysentery/Febrile DiarrheaNCT01618591Uniformed Services University of the Health Sciences384
已完成
2 期
Study With a Topical Gel to Treat Common Warts in AdultsWartsNCT00117923Graceway Pharmaceuticals, LLC88